1. Home
  2. AXR vs NKTX Comparison

AXR vs NKTX Comparison

Compare AXR & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • NKTX
  • Stock Information
  • Founded
  • AXR 1961
  • NKTX 2015
  • Country
  • AXR United States
  • NKTX United States
  • Employees
  • AXR N/A
  • NKTX N/A
  • Industry
  • AXR Homebuilding
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXR Real Estate
  • NKTX Health Care
  • Exchange
  • AXR Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • AXR 110.0M
  • NKTX 131.3M
  • IPO Year
  • AXR N/A
  • NKTX 2020
  • Fundamental
  • Price
  • AXR $21.79
  • NKTX $1.93
  • Analyst Decision
  • AXR
  • NKTX Strong Buy
  • Analyst Count
  • AXR 0
  • NKTX 6
  • Target Price
  • AXR N/A
  • NKTX $15.00
  • AVG Volume (30 Days)
  • AXR 13.1K
  • NKTX 657.1K
  • Earning Date
  • AXR 03-07-2025
  • NKTX 05-20-2025
  • Dividend Yield
  • AXR N/A
  • NKTX N/A
  • EPS Growth
  • AXR 472.07
  • NKTX N/A
  • EPS
  • AXR 2.41
  • NKTX N/A
  • Revenue
  • AXR $58,052,000.00
  • NKTX N/A
  • Revenue This Year
  • AXR N/A
  • NKTX N/A
  • Revenue Next Year
  • AXR N/A
  • NKTX N/A
  • P/E Ratio
  • AXR $9.09
  • NKTX N/A
  • Revenue Growth
  • AXR 30.35
  • NKTX N/A
  • 52 Week Low
  • AXR $15.88
  • NKTX $1.31
  • 52 Week High
  • AXR $39.67
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • AXR 47.78
  • NKTX 51.05
  • Support Level
  • AXR $21.15
  • NKTX $1.81
  • Resistance Level
  • AXR $22.97
  • NKTX $2.16
  • Average True Range (ATR)
  • AXR 1.06
  • NKTX 0.16
  • MACD
  • AXR -0.09
  • NKTX -0.02
  • Stochastic Oscillator
  • AXR 23.78
  • NKTX 25.53

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: